featured
Dorzagliatin Monotherapy in Chinese Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dorzagliatin Monotherapy in Chinese Patients With Type 2 Diabetes: A Dose-Ranging, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study
Lancet Diabetes Endocrinol 2018 May 04;[EPub Ahead of Print], D Zhu, S Gan, Y Liu, J Ma, X Dong, W Song, J Zeng, G Wang, W Zhao, Q Zhang, Y Li, H Fang, X Lv, Y Shi, H Tian, L Ji, X Gao, L Zhang, Y Bao, M Lei, L Li, L Zeng, X Li, X Hou, Y Zhao, T Hu, X Ge, G Zhao, Y Li, Y Zhang, L ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.